France: In non-COPD patients at high risk of extubation failure, prophylactic noninvasive ventilation (NIV) alternating with ...
Lungpacer Medical announced that it received FDA premarket approval for its flagship AeroPace neurostimulation system.
Lungpacer Medical announced that its AeroPace® System has received premarket approval (PMA) from the U.S. Food and Drug ...
Lungpacer Medical’s AeroPace System uses neurostimulation via an electrode-containing cardiovascular-catheter and software-controlled system to contract and strengthen the diaphragm in patients on ...